Linden Lake Venture Capital
Linden Lake Ventures, founded in 2019 and based in Bethesda, Maryland, is a venture capital firm that specializes in early-stage biotechnology investments. The firm focuses on developing transformative molecular medicines for patients in need, targeting sectors such as oncology, immunology, hepatology, cardiovascular, respiratory, neurology, orphan diseases, small molecules, biologics, and gene and cell therapy. Linden Lake Ventures employs a hands-on investment approach, primarily concentrating on pre-clinical and phase I technologies to foster innovation in the biotechnology landscape.
Vesigen, Inc. is a biotechnology company focused on developing innovative therapeutic products that utilize extracellular vesicle delivery technology to target intracellular sites. Founded in 2020 and based in Cambridge, Massachusetts, the company employs its proprietary ARMMs technology to facilitate the direct delivery of various payloads, including RNAs, proteins, and gene-editing complexes, into the cytoplasm of target cells. This approach aims to overcome the challenges associated with intracellular drug delivery, thereby broadening the range of potential druggable targets and enabling the creation of novel treatments for various diseases. Vesigen's mission is to address unmet medical needs through its advanced therapeutic solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.